✦ LIBER ✦

Review article: anti TNF-α induced psoriasis in patients with inflammatory bowel disease

✍ Scribed by G. FIORINO; M. ALLEZ; A. MALESCI; S. DANESE

Book ID: 108605581
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 169 KB
Volume: 29
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2009.03955.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systematic review: steroid withdrawal in

Systematic review: steroid withdrawal in anti-TNF-treated patients with inflammatory bowel disease

✍ E. Bultman; E. J. Kuipers; C. J. Van Der Woude 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Review article: anti-tryptase therapy in

Review article: anti-tryptase therapy in inflammatory bowel disease

✍ N. YOSHIDA; Y. ISOZAKI; T. TAKAGI; S. TAKENAKA; R. UCHIKAWA; N. ARIZONO; T. YOSH 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 744 KB

Review article: reproduction in the pati

Review article: reproduction in the patient with inflammatory bowel disease

✍ Z. S. HEETUN; C. BYRNES; P. NEARY; C. O’MORAIN 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 555 KB

Review article: improving adherence to m

Review article: improving adherence to medication in patients with inflammatory bowel disease

✍ A. ROBINSON 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Review article: influenza A (H1N1) virus

Review article: influenza A (H1N1) virus in patients with inflammatory bowel disease

✍ J.-F. RAHIER; Y. YAZDANPANAH; N. VIGET; S. TRAVIS; J.-F. COLOMBEL 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Liver diseases associated with anti-tumo

Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease

✍ Carla S. Coffin; Hughie F. Fraser; Remo Panaccione; Subrata Ghosh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

The conventional treatment of inflammatory bowel disease (IBD) has focused on nonspecifically targeting mucosal inflammation. In the last decade, with the advent of novel biological agents that directly inhibit proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-a), rapid progress ha